Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Both tick-borne encephalitis (TBE) virus and Borrelia burgdorferi depend for their survival on a tick-borne transmission cycle involving diverse vertebrate hosts and ixodid (primarily Ixodes) tick species. Increasing evidence strongly suggests that a key factor in successful transmission is the ability of these pathogens to exploit the pharmacological properties of their vector tick's saliva. Proteins and other chemicals, secreted in tick saliva, control the vertebrate hosts' haemostatic, inflammatory and immune responses in order to facilitate blood-feeding. Such bioactive saliva molecules include immunoglobulin-binding proteins, histamine-binding proteins, natural killer cell and interferon regulators, and complement inhibitors. By unravelling the contents of tick saliva and understanding their interactions with host and pathogen, we may identify new strategies for disease control.


Journal article


Zentralbl Bakteriol

Publication Date





492 - 505


Animals, Bacterial Vaccines, Birds, Borrelia burgdorferi Group, Complement Inactivator Proteins, Disease Vectors, Encephalitis Viruses, Tick-Borne, Encephalitis, Tick-Borne, Female, Histamine, Host-Parasite Interactions, Immunoglobulin G, Ixodes, Killer Cells, Natural, Lyme Disease, Male, Proteins, Rodentia, Saliva, Viral Vaccines